The behavioral effects of a mixed efficacy antinociceptive peptide, VRP26, following chronic administration in mice.
about
Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain.In Vivo Effects of μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Peptidomimetics Following Acute and Repeated Administration.Delta/mu opioid receptor interactions in operant conditioning assays of pain-depressed responding and drug-induced rate suppression: assessment of therapeutic index in male Sprague Dawley rats.
P2860
The behavioral effects of a mixed efficacy antinociceptive peptide, VRP26, following chronic administration in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The behavioral effects of a mi ...... hronic administration in mice.
@en
The behavioral effects of a mi ...... hronic administration in mice.
@nl
type
label
The behavioral effects of a mi ...... hronic administration in mice.
@en
The behavioral effects of a mi ...... hronic administration in mice.
@nl
prefLabel
The behavioral effects of a mi ...... hronic administration in mice.
@en
The behavioral effects of a mi ...... hronic administration in mice.
@nl
P2093
P2860
P1433
P1476
The behavioral effects of a mi ...... hronic administration in mice.
@en
P2093
Brett T Boyer
Emily M Jutkiewicz
Henry I Mosberg
Jessica P Anand
P2860
P2888
P304
P356
10.1007/S00213-016-4296-8
P577
2016-04-27T00:00:00Z